A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Eosinophilic Esophagitis
In brief
This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study.
Key facts
- Study ID
- NCT04322708
- Run by
- Allakos Inc.
- People needed
- 277
- Starts
- 2020-07-06
- Expected to finish
- 2022-01-18
- Last updated by the study team
- 2024-01-02
Who can join
Age: 12 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Allakos Investigational Site — Huntsville, Alabama, United States
- Allakos Investigational Site — Gilbert, Arizona, United States
- Allakos Investigational Site — Phoenix, Arizona, United States
- Allakos Investigational Site — Phoenix, Arizona, United States
- Allakos Investigational Site — Scottsdale, Arizona, United States
- Allakos Investigational Site — Little Rock, Arkansas, United States
- Allakos Investigational Site — La Jolla, California, United States
- Allakos Investigational Site — Los Angeles, California, United States
- Allakos Investigational Site — Oakland, California, United States
- Allakos Investigational Site — Santa Monica, California, United States
- Allakos Investigational Site — Tustin, California, United States
- Allakos Investigational Site — Ventura, California, United States
- Allakos Investigational Site — Walnut Creek, California, United States
- Allakos Investigational Site — Aurora, Colorado, United States
- Allakos Investigational Site — Centennial, Colorado, United States
- Allakos Investigational Site — Brandon, Florida, United States
- Allakos Investigational Site — Edgewater, Florida, United States
- Allakos Investigational Site — Jacksonville, Florida, United States
- Allakos Investigational Site — Miami, Florida, United States
- Allakos Investigational Site — Orlando, Florida, United States
- Allakos Investigational Site — Orlando, Florida, United States
- Allakos Investigational Site — Tampa, Florida, United States
- Allakos Investigational Site — Tampa, Florida, United States
- Allakos Investigational Site — Atlanta, Georgia, United States
- Allakos Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.